CollPlant Biotechnologies Ltd. (CLGN)
CLGN Stock Price Chart
Explore CollPlant Biotechnologies Ltd. interactive price chart. Choose custom timeframes to analyze CLGN price movements and trends.
CLGN Company Profile
Discover essential business fundamentals and corporate details for CollPlant Biotechnologies Ltd. (CLGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
31 Jan 2018
Employees
57.00
Website
https://www.collplant.comCEO
Yehiel Tal
Description
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
CLGN Financial Timeline
Browse a chronological timeline of CollPlant Biotechnologies Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 May 2026
Upcoming earnings on 26 Nov 2025
EPS estimate is $0.38.
Earnings released on 20 Aug 2025
EPS came in at -$0.28 falling short of the estimated -$0.10 by -180.00%, while revenue for the quarter reached $179.00K , missing expectations by -98.92%.
Earnings released on 28 May 2025
EPS came in at -$0.13 surpassing the estimated -$0.37 by +64.86%, while revenue for the quarter reached $2.06M , missing expectations by -76.94%.
Earnings released on 26 Mar 2025
EPS came in at -$0.34 surpassing the estimated -$0.42 by +19.05%, while revenue for the quarter reached $164.00K , beating expectations by +64.00%.
Earnings released on 27 Nov 2024
EPS came in at -$0.38 falling short of the estimated -$0.28 by -35.71%, while revenue for the quarter reached $4.00K , missing expectations by -98.90%.
Earnings released on 20 Aug 2024
EPS came in at -$0.37 falling short of the estimated -$0.35 by -5.71%, while revenue for the quarter reached $249.00K , missing expectations by -40.71%.
Earnings released on 4 Apr 2024
EPS came in at -$0.42 falling short of the estimated -$0.35 by -20.00%, while revenue for the quarter reached $98.00K , missing expectations by -83.67%.
Earnings released on 25 Jan 2024
EPS came in at -$0.24 falling short of the estimated -$0.07 by -242.86%, while revenue for the quarter reached $299.00K , missing expectations by -93.11%.
Earnings released on 29 Nov 2023
EPS came in at -$0.38 falling short of the estimated -$0.13 by -192.31%, while revenue for the quarter reached $43.00K , missing expectations by -99.01%.
Earnings released on 24 Aug 2023
EPS came in at $0.49 surpassing the estimated $0.02 by +3.17K%, while revenue for the quarter reached $10.18M , beating expectations by +5.26K%.
Earnings released on 24 May 2023
EPS came in at -$0.33 falling short of the estimated -$0.29 by -13.79%, while revenue for the quarter reached $433.00K , beating expectations by +80.42%.
Earnings released on 29 Mar 2023
EPS came in at -$0.39 falling short of the estimated -$0.21 by -85.71%, while revenue for the quarter reached $58.00K , beating expectations by +16.00%.
Earnings released on 1 Dec 2022
EPS came in at -$0.40 falling short of the estimated -$0.31 by -29.03%, while revenue for the quarter reached $109.00K , missing expectations by -96.48%.
Earnings released on 25 Aug 2022
EPS came in at -$0.39 falling short of the estimated -$0.08 by -387.50%, while revenue for the quarter reached $66.00K , missing expectations by -97.69%.
Earnings released on 26 May 2022
EPS came in at -$0.36 falling short of the estimated -$0.14 by -157.14%, while revenue for the quarter reached $66.00K , missing expectations by -97.59%.
Earnings released on 24 Mar 2022
EPS came in at -$0.30 falling short of the estimated -$0.26 by -15.38%, while revenue for the quarter reached $310.00K , missing expectations by -8.28%.
Earnings released on 18 Nov 2021
EPS came in at -$0.29 falling short of the estimated -$0.28 by -3.57%, while revenue for the quarter reached $140.00K , missing expectations by -99.34%.
Earnings released on 19 Aug 2021
EPS came in at -$0.30 falling short of the estimated -$0.10 by -200.00%, while revenue for the quarter reached $691.00K .
Earnings released on 27 May 2021
EPS came in at $0.88 surpassing the estimated $0.51 by +72.55%, while revenue for the quarter reached $14.50M .
Earnings released on 26 Mar 2021
EPS came in at -$0.42 falling short of the estimated -$0.30 by -40.00%, while revenue for the quarter reached $557.00K .
Earnings released on 1 Dec 2020
EPS came in at $0.07 falling short of the estimated $0.92 by -92.39%, while revenue for the quarter reached $4.15M .
CLGN Stock Performance
Access detailed CLGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.